Desiree Granados Quick Summary: Cannabis use for Friedreichs ataxia focuses on symptom management, including pain and muscle rigidity relief, through endocannabinoid system interaction, but it is not a disease-modifying therapy and research in this rare neurodegenerative condition is limited
Once a week, on the same day, you inject yourself with the Wegovy pen
Extra-gradual titration, proactive dietary management, and close communication with a gastroenterologist are essential for this population
Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)
Central Standard Time [CST])